SJS Investment Consulting’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.1K Buy
313
+62
+25% +$1.07K ﹤0.01% 1719
2026
Q2
$4.51K Buy
+251
New +$3.51K ﹤0.01% 1432
2024
Q4
– Sell
-3
Closed -$55 – 1652
2024
Q3
$55 Sell
3
-5
-63% -$116 ﹤0.01% 1610
2024
Q2
$234 Sell
8
-7
-47% -$208 ﹤0.01% 1476
2024
Q1
$532 Sell
15
-1
-6% -$40 ﹤0.01% 1264
2023
Q4
$697 Buy
16
+5
+45% +$197 ﹤0.01% 1109
2023
Q3
$421 Sell
11
-3
-21% -$126 ﹤0.01% 1271
2023
Q2
$576 Sell
14
-6
-30% -$289 ﹤0.01% 1113
2023
Q1
$1.15K Buy
20
+3
+18% +$169 ﹤0.01% 834
2022
Q4
$953 Buy
17
+9
+113% +$458 ﹤0.01% 954
2022
Q3
$0 Buy
+8
New +$410 ﹤0.01% 1262
2022
Q1
$0 Buy
+2
New +$132 ﹤0.01% 997

Other funds holding IART

SJS Investment Consulting's IART Position: Q3 2026 in Review

SJS Investment Consulting increased its Integra LifeSciences (IART) stake by 25% in Q3 2026, buying an estimated $1.07K and bringing the position to 313 shares worth $5.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

SJS Investment Consulting first reported a position in IART in Q1 2022 and has held it in 12 quarters since. 115 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • SJS Investment Consulting held 313 shares of Integra LifeSciences worth $5.1K as of Q3 2026.
  • SJS Investment Consulting bought 62 Integra LifeSciences shares in Q3 2026, an estimated $1.07K.
  • Integra LifeSciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1719 holding.
  • SJS Investment Consulting first reported a position in Integra LifeSciences in Q1 2022 and has held it in 12 quarters since.
  • 115 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.